NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-050-2012-0-JP-14 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases JP DIV 2020-026808 Pending
NCI E-099-2014-0-EP-11 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF EP DIV 20158336.6 Issued
NIAID E-145-2011-0-AU-16 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria AU DIV 2020201140 Issued
NINDS E-001-2019-1-EP-03 Handgrip Relaxometer Devices EP National Stage 20710721.0 Pending
NINDS E-001-2019-1-PCT-01 Handgrip Relaxometer Devices PCT PCT COMB PCT/US2020/018273 Expired
NCI E-243-2015-0-US-05 ANTI-CD276 CHIMERIC ANTIGEN RECEPTORS US CON 16/788,895 Abandoned
NIAID E-147-2015-0-EP-14 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION EP DIV 20156778.1 Pending
NCI E-053-2019-0-PCT-02 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES PCT PCT PCT/US2020/17515 Expired
NIAID E-131-2015-2-US-09 lNEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US CON 16/786,267 Abandoned
NCI E-171-2018-9-US-05 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/786,013 Abandoned
NCI E-053-2019-0-CA-09 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES CA National Stage 3128871 Pending
NIAID E-032-2019-0-HK-08 NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF HK EP 62022053678.8 Pending
NIAID E-032-2019-0-CN-04 Adaptive Modular Nanoparticle-Based Universal Influenza Vaccine Platform CN National Stage 202080013357.7 Pending
NIAID E-032-2019-0-EP-05 NANOPARTICLE-BASED INFLUENZA VIRUS VACCINES AND USES THEREOF EP National Stage 20710367.2 Pending
NIAID E-032-2019-0-KR-06 Adaptive Modular Nanoparticle-Based Universal Influenza Vaccine Platform KR National Stage 10-2021-7026196 Pending
NIAID E-032-2019-0-PCT-02 Adaptive Modular Nanoparticle-Based Universal Influenza Vaccine Platform PCT PCT PCT/US2020/017216 Expired
NIAID E-032-2019-0-AU-03 Nanoparticle-based Influenza Virus Vaccines and Uses Thereof AU National Stage 2020219803 Pending
NHLBI E-011-2016-0-US-03 CLOSED-ENDED, LINEAR, DUPLEX ADENOASSOCIATED VIRUS DNA, AND USES THEREOF US National Stage 16/637,152 11549125 Issued PDF
NEI E-165-2017-0-US-04 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES US National Stage 16/636,945 11547708 Issued PDF
NIAID E-120-2001-1-AU-03 Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses AU DIV 2020200863 Expired
NIEHS E-210-2017-0-US-06 COMPOSITIONS AND METHODS FOR INHIBITING HIV-1 REVERSE TRANSCRIPTASE US National Stage 16/637,092 Abandoned
NICHD E-014-2019-0-US-02 COMPOSITE GELS AND METHODS OF USE THEREOF US ORD 16/783,494 Pending
NCI E-750-2013-0-JP-20 Methods for Subtyping Lymphoma Types by Means of Expression Profiling JP DIV 2020-018323 Issued
NCI E-040-2012-0-JP-55 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen JP DIV 2020-018005 Issued
NIDDK E-064-2004-0-US-61 The Use Of Leptin For Treating Human Lipotrophy US CON 16/782,773 Abandoned
NCI E-094-2017-2-US-04 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment US CON 16/780,325 Pending
NCI E-190-2014-0-US-41 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS US CON 16/778,361 11110181 Issued PDF
NCI E-244-2015-0-US-11 BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE US DIV 16/778,043 11034740 Issued PDF
NCATS E-202-2016-4-US-04 Repurposing CDK Inhibitors For Treatment Of Zika Virus Infection US CON 16/779,132 10940188 Issued PDF
CC E-103-2018-0-PCT-01 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS PCT PCT COMB PCT/US2020/016262 Expired
CC E-103-2018-0-EP-02 METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS EP National Stage 20708995.4 Pending
NIAID E-005-2017-0-US-06 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS US National Stage 16/635,240 11535651 Issued PDF
NIAID E-145-2015-3-US-14 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US CON 16/777,559 10869856 Issued PDF
NIAID E-089-2019-0-PCT-02 SIRPalpha Expression On T Cells Is A Biomarker For Functional T Cells During Exhaustion PCT PCT PCT/US2020/015905 Expired
NIBIB E-047-2019-0-PCT-02 Development Of Dual Albumin Binder For Long-lasting Therapeutic Peptide Delivery PCT PCT PCT/US2020/015818 Expired
NIDCR E-190-2015-0-US-05 METHOD AND DEVICE FOR DETECTING ANTIGEN-SPECIFIC ANTIBODIES IN A BIOLOGICAL FLUID SAMPLE BY USING NEODYMIUM MAGNETS US DIV 16/776,831 Abandoned
NIBIB E-047-2019-0-CN-03 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE CN National Stage 2020800116961 Issued
NIBIB E-047-2019-0-HK-08 Development Of Dual Albumin Binder For Long-lasting Therapeutic Peptide Delivery HK EP 62022046553.3 Issued
NIBIB E-047-2019-0-EP-04 Development Of Dual Albumin Binder For Long-lasting Therapeutic Peptide Delivery EP National Stage 20708884.0 Issued
NIBIB E-047-2019-0-IL-05 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE IL National Stage 284898 Issued
NIBIB E-047-2019-0-SG-06 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE SG National Stage 11202108081P Issued
NCI E-195-2018-0-PCT-02 DETECTION OF BCL-2 FAMILY HETERODIMER COMPLEXES AND USE THEREOF PCT PCT PCT/US2020/015694 Expired
NCI E-193-2017-0-US-03 Ultrasound Sensitive Peptide Nanoparticles For Spatially Resolved Molecule Delivery US National Stage 16/634,679 Pending
NIDCR E-186-2009-0-US-08 APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS US CON 16/773,982 Abandoned
NCI E-014-2018-0-US-07 Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development US DIV 16/773,379 Pending
NIAID E-089-2002-1-EP-88 Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 EP DIV 20153909.5 Expired
NCI E-148-2011-0-US-38 ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER US CON 16/751,643 11124580 Issued PDF
NCI E-217-2011-1-US-12 A NOVEL INTERFERON-(lambda)4 (IFNL-4) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF US CON 16/752,105 Abandoned
NIAID E-154-2010-1-US-15 CHIMPANZEE ADENOVIRAL VECTOR-BASED FILOVIRUS VACCINES US CON 16/751,470 Pending
NINDS E-208-2020-0-US-02 MOLECULES TARGETING SURVIVAL MOTOR NEURON 2 US ORD 16/750,531 Abandoned